Effects of vardenafil, a phosphodiesterase type-5 inhibitor, on sphincter of Oddi motility in patients with suspected biliary sphincter of Oddi dysfunction. [electronic resource]
Producer: 20090806Description: 1111-6 p. digitalISSN:- 1097-6779
- Administration, Topical
- Adult
- Aged
- Cholangiopancreatography, Endoscopic Retrograde
- Common Bile Duct Diseases -- drug therapy
- Constriction, Pathologic -- drug therapy
- Female
- Humans
- Imidazoles -- adverse effects
- Male
- Manometry
- Middle Aged
- Phosphodiesterase 5 Inhibitors
- Phosphodiesterase Inhibitors -- adverse effects
- Piperazines -- adverse effects
- Postcholecystectomy Syndrome -- drug therapy
- Prospective Studies
- Sphincter of Oddi -- drug effects
- Sphincterotomy, Endoscopic
- Sulfones -- adverse effects
- Triazines -- adverse effects
- Vardenafil Dihydrochloride
- Vasodilator Agents -- adverse effects
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.